연구동향 분석
박사

Study for the Signaling Pathways Determining the Angiogenic Behaviors in Tumor Microenvironment

이슬 2020년

논문상세정보
인용/피인용
' Study for the Signaling Pathways Determining the Angiogenic Behaviors in Tumor Microenvironment' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Angiogenesis
  • S6K1
  • Tumor microenvironment
  • mTOR
  • pkm2
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
224 0

0.0%

' Study for the Signaling Pathways Determining the Angiogenic Behaviors in Tumor Microenvironment' 의 참고문헌

  • mTORC1 drives HIF-1ес and VEGF-A signalling via multiple mechanisms involving 4E-BP1 , S6K1 and STAT3
    [2015]
  • mTORC1 and mTORC2 in cancer and the tumor microenvironment .
    36:2191-2201 [2016]
  • mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors
    6:20250 . [2016]
  • mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt .
    66 ( 3 ) :1500-8 . [2006]
  • Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis , and IgG immune complexes potentiate the process
    62 ( 23 ) :7042-9 . [2002]
  • The translational landscape of mTOR signalling steers cancer initiation and metastasis
    485 ( 7396 ) :55-61 . [2012]
  • The TSC-mTOR pathway regulates macrophage polarization
    [2013]
  • Tang D. PKM2 contributes to cancer metabolism
    356 ( 2 Pt A ) :184-91 . [2015]
  • Tan M. Targeting cellular metabolism to improve cancer therapeutics
    4 : e532 . [2013]
  • Synergistic up-regulation of vascular endothelial growth factor ( VEGF ) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter
    18 ( 1 ) :14-23 [2007]
  • Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer
    14 ( 5 ) : e0217131 . [2019]
  • Stevens T. Critical role for lactate dehydrogenase A in aerobic glycolysis that sustains pulmonary microvascular endothelial cell proliferation .
    299 , L513-22 [2010]
  • Stabilization of hypoxia-inducible factor-1ес in buffer containing cobalt chloride for Western blot analysis .
    416 ( 1 ) :120-2 . [2011]
  • S6K1-/-/S6K2-/mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway .
    24 ( 8 ) :3112-24 . [2004]
  • S6K1 phosphorylation of H2B mediates EZH2 trimethylation of H3 : A determinant of early adipogenesis .
    62:443-452 [2016]
  • Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
    0.260416667 [2014]
  • Role of mTOR Signaling in Tumor Microenvironment : An Overview
    19 ( 8 ) : E2453 . [2018]
  • Role of PFKFB3-driven glycolysis in vessel sprouting
    154 ( 3 ) :651-63 . [2013]
  • Ribosomal protein S6 , a target of rapamycin , is involved in the regulation of rRNA genes by possible epigeneticChanges in Arabidopsis
    289 ( 7 ) :3901-12 [2014]
  • Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin
    22 ( 20 ) :7004-14 . [2002]
  • Regulation of endothelialCell proliferation and vascular assembly through distinct mTORC2 signaling pathways
    35 ( 7 ) :1299-313 [2015]
  • Recommendations for myeloid-derived suppressorCell nomenclature andCharacterization standards .
    7:12150 [2016]
  • Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis .
    8 ( 10 ) :839-47 . [2012]
  • Plas DR. Requirement for ribosomal protein S6 kinase 1 to mediate glycolysis and apoptosis resistance induced by Pten deficiency .
    108 : 2361 ? 2365 [2011]
  • PKM2 regulates endothelialCell junction dynamics and angiogenesis via ATP production
    9 ( 1 ) :15022 . [2019]
  • PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumorCells ..Cell
    155 ( 2 ) :397-409 . [2013]
  • Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation .
    18 ( 7 ) :632-44 [2016]
  • Mechanisms of adverse effects of anti-VEGF therapy for cancer
    96 ( 12 ) :1788-95 . [2007]
  • Lu Z. Pyruvate kinase M2 at a glance .
    128 ( 9 ) :1655-60 . [2015]
  • Loss of pyruvate kinase M2 limits growth and triggers innate immune signaling in endothelial cells
    9 ( 1 ) :4077 . [2018]
  • Lactate : mirror and motor of tumor malignancy
    14 ( 3 ) :267-74 . [2004]
  • KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi 's sarcoma .
    18 ( 4 ) :477-88 . [2015]
  • JMJD8 Regulates Angiogenic Sprouting and Cellular Metabolism by Interacting With Pyruvate Kinase M2 in Endothelial Cells .
    36 ( 7 ) :1425-33 . [2016]
  • Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection
    79 ( 5 ) :490-501 . [2001]
  • IL-12 induces IFN-еу expression and secretion in mouse peritoneal macrophages
    159 : 3490 [1997]
  • Hypoxic gene activation by lipopolysaccharide in macrophages : implication of hypoxia-inducible factor 1alpha
    103 ( 3 ) :1124-30 . [2004]
  • Hypoxia-inducible factor 1 alpha is regulated by the mammalian target of rapamycin ( mTOR ) via an mTOR signaling motif .
  • Hanahan D. Modes of resistance to anti-angiogenic therapy
    8 ( 8 ) :592 603 . [2008]
  • Hallmarks of cancer : the next generation
    144 ( 5 ) :646-74 [2011]
  • Gottlieb E. Rocking cell metabolism : revised functions of the key glycolytic regulator PKM2 in cancer
    37 ( 8 ) :309-16 . [2012]
  • Functions and regulation of the 70kDa ribosomal S6 kinases I nt
    43 ( 1 ) :47 59 . [2011]
  • Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
    513 ( 7519 ) :559-63 . [2014]
  • Ferrara N. Developmental and pathological angiogenesis .
    27:563-84 [2011]
  • Evidence for an alternative glycolytic pathway in rapidly proliferating cells
    329 ( 5998 ) :1492-9 [2010]
  • Endothelial pyruvate kinase M2 maintains vascular integrity .
    128 ( 10 ) :4543-4556 . [2018]
  • Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis .
    68 ( 19 ) :8183-8 . [2008]
  • De Bock K. The Warburg Effect in Endothelial Cells and its Potential as an Anti-angiogenic Target in Cancer
    0.319444444 [2018]
  • DAmore PA. Hypoxic induction of vascular endothelial growth factor ( VEGF ) in human epithelial cells is mediated by increases in mRNA stability
    370 ( 3 ) :203-8 [1995]
  • Characterization of murine macrophages from bone marrow , spleen and peritoneum
    0.5875 [2013]
  • Carmeliet P. Role of endothelial cell metabolism in vessel sprouting
    18 ( 5 ) :634-47 . [2013]
  • Carmeliet P. Endothelial Cell Metabolism in Health and Disease
    28 ( 3 ) :224-236 . [2018]
  • Balancing Akt with S6K : implications for both metabolic diseases and tumorigenesis .
    167 ( 3 ) :399-403 . [2004]
  • Anti-angiogenic therapy for cancer : current progress , unresolved questions and future directions
    17 ( 3 ) :471-94 . [2014]
  • An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
    19 ( 9 ) :1114-23 . [2013]
  • Activation of a metabolic gene regulatory network downstream of mTOR complex 1 .
    39 : 171 ? 183 [2010]
  • A model of human tumor dormancy : an angiogenic switch from the nonangiogenic phenotype
    98 ( 5 ) :316-25 . [2006]
  • 3. Rosen L. Antiangiogenic strategies and agents in clinical trials. Oncologist. 2000; 5 Suppl 1:20-7.
  • 2. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat. Rev. Drug Discov. 2007; 6(4):273-86.
  • 11. Mazurek S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol. 2011; 43(7):969?980.
  • , P. von Breitenbuch , M. Steinbauer , G. Koehl , E.K . Geissler . etJ. Kim , V.G .Cooke ,C.C . Wu , V.S
    al